Table 2.
Postoperative outcome
| Control (n = 20) | Intervention (n = 20) | P-value* | Dobu + (n = 10) | P-value § | |
|---|---|---|---|---|---|
| Number of complications (n) | 20 | 11 | 0.23 | 7 | 0.49 |
| Patients without complications (n) | 7 | 11 | 0.34 | 4 | 1.00 |
| Complications | 0.35 | 0.56 | |||
| Pneumonia | 4 | 5 | 3 | ||
| Respiratory failure | 1 | ||||
| Cardiac failure | 1 | 1 | |||
| Supraventricular arrhythmia | 3 | 1 | |||
| Relaparotomy | 1 | 1 | 1 | ||
| Ileus | 3 | 1 | 1 | ||
| Urinary tract infection | 2 | 1 | 1 | ||
| Renal failure | 1 | ||||
| TIA | 1 | ||||
| Delirium | 4 | ||||
| Hematoma | 1 | ||||
| Death | 1 | ||||
| SOFA score | 5 [2-12] | 6 [5-11] | 0.73 | 5 [5-9] | 0.78 |
| TISS score | 25 [21–33] | 26 [22–30] | 0.95 | 28 [26–48] | 0.96 |
| LOS ICU (hours) | 22 [21–45] (n = 15) | 22 [17–38] (n = 15) | 0.53 | 22 [17–43] (n = 8) | 0.50 |
| LOS PACU (hours) | 18 [17-22] (n = 5) | 18 [13-22] (n = 5) | 0.75 | 17 [17,18] (n = 2) | 0.42 |
| LOS FFD (hours) | 18 [8–37] | 17 [6-23] | 0.39 | 18 [13–36] | 0.70 |
| LOS Hosp (days) | 12 [9-17] | 13 [7-17] | 0.96 | 15 [8-25] | 0.72 |
Dobu+, subgroup of intervention subjects that did receive dobutamine; SOFA, sequential organ failure assessment; TIA, transient ischemic attack; LOS, length of stay; ICU, intensive care unit; PACU, post anesthesia care unit; FFD, fit for discharge; Hosp, hospital; *Control versus Intervention; § Control versus Dobu+.